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Purpose: The Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical 
Examinations – Questionnaire (ESSENCE-Q) was developed as a brief screener to identify 
children with developmental concerns who might have neurodevelopmental disorders (NDDs). 
This study aimed to translate the ESSENCE-Q into south Slavic languages, namely, Bosnian, 
Bulgarian, Croatian, Macedonian, Montenegrin, Serbian, and Slovenian, and to evaluate its 
psychometric properties for screening purposes in clinical settings.
Patients and methods: In the study, the ESSENCE-Q was completed for 251 “typically devel-
oping” children and 200 children with 1 or more diagnosed NDDs, all aged 1–6 years. Internal 
consistency and construct validity were tested first, followed by generating receiver operating 
characteristic curves and the area under the curve. Optimal cutoff values were then explored.
Results: The Cronbach’s α coefficients were 0.91, 0.88, and 0.86 for ESSENCE-Q parent-
completed form, and the telephone and direct interview forms administered by trained nurse or 
specialist, respectively. The 3 versions produced area under the curve values (95% confidence 
interval): 0.96 (0.93–0.99), 0.91 (0.86–0.95), and 0.91 (0.86–0.97), respectively. An optimal 
cutoff for ESSENCE-Q parent-completed form was found to be $3 points, while for the tele-
phone and direct interviews, it was $5 points.
Conclusion: We found adequate measurement properties of the south Slavic languages versions 
of the ESSENCE-Q as a screener for NDDs in clinical settings. This study provided additional 
data supporting sound psychometric properties of the ESSENCE-Q.
Keywords: early screening, questionnaire, autism, intellectual disability
Introduction
Neurodevelopmental disorders (NDDs) are a group of conditions originating early 
in life with a wide range of developmental deficits.1 Roughly estimated, the cumu-
lative prevalence of all NNDs is about 10% in children and adolescents ,18 years 
of age.1,2 The deficits are present in 1 or more emotional, cognitive, behavioral, 
motor, and/or social communication developmental aspects, with a range of impair-
ments in personal, social, and, later on, academic, and/or occupational functioning. 
According to the most recent classification, there are clearly separated NDDs, such 
as intellectual disability/intellectual developmental disorder (IDD), communication 
disorders, autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder 
(ADHD), neurodevelopmental motor disorders, and specific learning disorders.1 
Due to common neurobiological and genetic etiologies, NDDs frequently co-occur, 
overlap, and/or precede one another, bringing a huge challenge for proper diagnosis 
and treatment.3
Evidence indicates that early identification and treatment initiation have beneficial 
developmental effects and lead to favorable outcomes in children with NDDs.4–7 
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In this regard, early screening is of significant importance 
and many different screening questionnaires have been 
developed over the past 2 decades.8–10 However, from clinical 
and research point of view, there are few challenges to con-
sider when screening with available questionnaires.2,11,12 
Available screening questionnaires generally categorize 
the child as having or not having 1 particular NDD based 
on the presence of specific symptoms/deficits related to 
that disorder, while mainly ignoring the presence of other 
developmental deficits, which could also categorize the 
child as having another or additional NDD. Related to this, a 
majority of these questionnaires is focusing on 1 or 2 NDDs 
only, which although maximizing the sensitivity and speci-
ficity for selecting 1 specific disorder during screening, does 
not reflect the real-world circumstances in which NDDs are 
co-occurring and overlapping in young children.1 In addi-
tion, when screening for a particular disorder, it is required 
to take into account early developmental aspects and the 
course of the disorder screened, which creates problems 
because NDDs present differently at different ages with 
symptoms changing markedly, which may also affect the 
results of the screening.13 Finally, specific screening ques-
tionnaires may have different performances when used for 
clinical- and community-based screening, with respect to 
wide ranges of symptoms and severity levels present in 
one or the other.
ESSENCE is an acronym for Early Symptomatic Syn-
dromes Eliciting Neurodevelopmental Clinical Examina-
tions referring to neurodevelopmental or neuropsychiatric 
disorders including IDD, ASD, ADHD, oppositional defiant 
disorder (ODD), tic disorders, developmental coordina-
tion disorder (DCD), speech and language disorder (SLD), 
and others.2 The concept was introduced with an idea 
to alert clinicians and researchers of the complexity and 
overlap of neurodevelopmental problems with early onset 
and to act toward diagnosis and treatments accordingly 
without putting children into mere “diagnostic boxes”.2 The 
ESSENCE-Questionnaire (ESSENCE-Q) was developed 
from the mentioned concept as a brief screener to identify 
children who may have neurodevelopmental difficulties, 
namely, difficulties in general development, communication/
language, social interrelatedness, perception, motor coor-
dination, attention, activity, behavior, mood, feeding, and/
or sleeping in the first years of childhood, which could all 
be seen as red flags for possible NDDs.14 The ESSENCE-Q 
is intended to be used in the form of a brief interview by a 
specialist/nurse or as a questionnaire to be completed by 
parents and/or caregivers. Those children who are identified 
as raising concern regarding development are referred for 
detailed diagnostic evaluation. Two psychometric studies 
of the questionnaire have been performed in Japan, one in a 
neurodevelopmental clinic and one in a child health center. 
These studies have demonstrated good internal consistency, 
sensitivity, and specificity for screening purposes, when it 
was used as a parent-completed and direct (ie, face-to-face) 
interview.12,15
The ESSENCE-Q could overcome the aforementioned 
challenges when screening with available questionnaires, 
particularly in detecting children with broader neurodevel-
opmental difficulties, but not only specific NDDs, and could 
be used in different settings, either clinical or non-clinical, 
which is especially relevant in low-resource settings and low-
middle income countries.16 In order to use the ESSENCE-Q 
as a gold standard for NDDs screening, more psychometric 
studies with different forms and language versions and in 
different clinical and non-clinical settings are needed.
The present study was organized with the aims to 1) trans-
late the ESSENCE-Q into 7 south Slavic languages, namely, 
Bosnian, Bulgarian, Croatian, Macedonian, Montenegrin, 
Serbian, and Slovenian and 2) evaluate its psychometric 
properties for screening purposes in clinical settings. Three 
ESSENCE-Q forms were considered; a parent form for self-
completion and telephone interview and direct interview 
administered by a specialist or a nurse.
Patients and methods
This is a clinic-based, multicenter validation study. The Ethics 
Committee of the Clinic for Neurology and Psychiatry for 
Children and Youth, Belgrade, Serbia, first approved the study 
and afterward, it was also approved by the relevant bodies of 
each included clinic where participants were recruited.
esseNce-Q
The ESSENCE-Q has 12 items covering concerns related 
to child’s 1) general development, 2) motor develop-
ment/milestones, 3) sensory reactions (eg, touch, sound, 
light, smell, taste, heat, cold, and pain), 4) communica-
tion/language/babble, 5) activity (overactivity/passivity) 
or impulsivity, 6) attention/concentration/“listening”, 
7) social interaction/interest in other children, 8) behavior 
(eg, repetitive and routine insistence), 9) mood (depressed, 
elated/manic, extreme irritability, and crying spells), 10) 
sleeping, 11) feeding, and 12) “funny spells”/absences. 
Response options are “Yes” (2 points), “Maybe/A little” 
(1 point), or “No” (0 point) for each item. Total score is a 
sum of all answered items (possible range 0–24).
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After receiving the author’s approval (C Gillberg), the 
ESSENCE-Q was translated into the South Slavic group of 
languages (ie, Bosnian, Bulgarian, Croatian, Macedonian, 
Montenegrin, Serbian, and Slovenian). South Slavic lan-
guages are considered to constitute a dialect continuum in a 
set of phonological, morphological, and lexical innovations 
(isoglosses) spoken mainly in Balkan countries, and also in 
other European countries.17 The members of the research 
team conducted the translation process separately for each 
language following the same procedure18 to ensure con-
tent equivalence with the original. The translation process 
included: forward translation (2 independent forward transla-
tions), reconciliation (1 single translation developed from the 
2 forward translations), backward translation (1 independent 
back-translation), harmonization (all forward and backward 
translations analyzed together and a pre-final version for a 
pilot testing developed), and pilot testing phase (several 
independent semi-structured interviews held with parents of 
children with NDDs). For all developed versions, there was 
no need to culturally adapt any item, considering that the 
terms used to describe developmental aspects are the same 
or very similar, common in the medical literature, and there 
are no cultural differences between the neighbor countries 
included. During the pilot testing phase, the instructions and 
10 items were estimated as comprehensive, precise, and rel-
evant for assessing developmental and emotional/behavioral 
difficulties in young children, thus they remained unchanged 
and no terms were added, replaced, or omitted. Nevertheless, 
in Item 2 (motor development/milestones), “milestones” was 
omitted, considering that most parents did not understand this 
word. In Item 12 (“funny spells”/absences), the slang “funny 
spells”, referring to an epileptic seizure, was not possible to 
translate accordingly with a slang. Therefore, in some ver-
sions, the translation was adapted as “looking weird for short 
periods of time” or “atypical behavior”, while “absence” 
was translated as “periods when one is looking absent” (the 
back-translation for this item is “Short periods when one 
is absent/looking lost for short periods of time”), with the 
original meaning preserved across the versions.
Participants and procedures
The participants in the present study were parents/caregivers 
of children referred for diagnostic and/or therapeutic purposes 
during January 2017–July 2017 to one of the following 
clinics: Clinic for Neurology and Psychiatry for Children 
and Adolescents Belgrade, Serbia; University Children’s 
Hospital Skopje, Macedonia; Department of Child Psychiatry, 
University Clinical Center Ljubljana, Slovenia; Department 
of Child and Adolescent Psychiatry, University Hospital 
St Marina Varna, Bulgaria; Pediatric Clinic, Clinical Center 
Sarajevo, Bosnia and Herzegovina; Mental Health Center 
Pljevlja, Montenegro; and Clinic for Children’s Disorders, 
Clinical Hospital Center Split, Croatia. In each clinic, the team 
included a child psychiatrist, pediatric neurologist/devel-
opmental and behavioral pediatrician, psychologist/speech 
therapist/IDD specialist, and neurodevelopmental nurse.
The main inclusion criterion for the study was a child’s age 
between 12 months and 6 years. Children were selected from 
the aforementioned centers through convenience sampling 
and all were separated into 2 groups; children with NDDs – 1) 
ESSENCE group and children with normal developmental 
trajectory – 2) non-ESSENCE group. A child was placed into 
the ESSENCE group if diagnosed with ASD, ADHD, ODD, 
tic disorders, DCD, SLD, IDD, global developmental delay, 
borderline intellectual functioning, behavioral phenotype 
syndromes, and/or neurological and seizures presenting with 
major behavioral/cognitive problems. The non-ESSENCE 
group consisted of children with age-expected neurodevelop-
ment and no ESSENCE diagnosis, but who might have had 
unspecific and unrelated symptoms to NDDs, such as feeding, 
sleeping, or attachment problems, separation anxiety, and/or 
similar. The first group was directly available to the teams 
of the study, while the non-ESSENCE group was derived 
from 3 sources. The first source was a pediatric department, 
where children were referred for physical disorders, but for 
whom was sought a psychological/psychiatric consultation 
from the team members. The second source was the database 
of children included in an early autism screening program 
in Serbia.19 The third source included children assessed for 
NDDs during the study period to which any neurological 
or psychiatric disorder was excluded. All child psychiatric/
NDDs were diagnosed using the Diagnostic and Statisti-
cal Manual of Mental Disorders – 51 and/or International 
Statistical Classification of Diseases – 10.20 Children were 
categorized into the 2 groups based on an established clinical 
protocol for a diagnostic assessment of each included center, 
including psychological and development assessment proce-
dures, whereas there was no common method (ie, psychologi-
cal and diagnostic scales) to implement at the beginning of 
the study and use across all centers.
Parents of selected children were informed about the study 
and those who agreed to participate and provided a written 
consent were included. The ESSENCE-Q was administered 
to parents as a self-complete form (ie, parent-completed form) 
and as a telephone or direct interview by trained nurse/
specialist (ie, telephone or direct interview form). In the case of 
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the children who were assessed before the study, mostly tele-
phone interviewing was organized. For the children assessed 
for NDDs during the study, the parent either self-completed 
the form or direct interviewing was organized. Each of the 
3 assessments was organized and supervised by the same 
specialist or nurse blinded for the health status of the child. 
The responsible person was instructed only to supervise a par-
ent self-completing and/or to conduct the interviews. It was 
allowed only to discuss the ESSENCE-Q items with the parents, 
without interfering with the responding or discussing the diag-
nosis of the child. Parent self-reporting or direct interviewing 
were organized during the diagnostic work-up of the child.
Over the study period, complete data were collected 
from 451 children; 37 (8.2%) from Bosnia and Herzegovina, 
50 (11.1%) from Bulgaria, 8 (1.8%) from Croatia, 109 (24.3%) 
from Macedonia, 16 (3.5%) from Montenegro, 148 (32.8%) 
from Serbia, and 83 (18.4%) from Slovenia. The non-ESSENCE 
group included 251 children (128 [51%] boys; mean age 3.1 
years), of whom 45 had some psychological symptoms not 
related to NDDs (15 [33.3%] fears/anxieties, 10 [22.2%] 
sleeping problems, and 20 [44.4%] other symptoms). The 
ESSENCE group included 200 children with 1 or more 
NDDs (142 [71%] boys; mean age 3.9 [1.2] years; Table 1).
In total, 147 ESSENCE-Q parent-completed forms 
were available; 48 (32.7%) for the ESSENCE and 99 (67.3%) 
for the non-ESSENCE group. ESSENCE-Q telephone interview 
forms were available for 188 children; 88 (46.8%) children in 
the ESSENCE and 100 (53.2%) in the non-ESSENCE group. 
ESSENCE-Q direct interview forms were available for 116 
children; 52 (44.8%) children in the ESSENCE and 64 (55.2%) 
in the non-ESSENCE group. Age and gender distributions of 
the participants in the ESSENCE and non-ESSENCE group 
are given in Table 2. For the parent-completed and telephone 
interview forms, data were provided for significantly older 
children in the ESSENCE, than in the non-ESSENCE group 
(P,0.05). For all 3 forms, more data were provided from male 
children in the ESSENCE, than in the non-ESSENCE group 
(P,0.02). Mothers mostly provided data (83.4%), followed 
by fathers (14.6%) and significant others (1.9%).
statistical analysis
The ESSENCE-Q total score was considered as a con-
tinuous variable. Cronbach’s α was used to test internal 
consistency. Confirmative factor analysis using Analysis 
of Moment Structures (AMOS) Version 7 was applied to 
test construct validity.21 A model represented by 12 items 
(ie, observable variables measuring specific aspects of 
child development) and 1 corresponding factor (ie, 
the overall development as a latent variable) was tested in 
AMOS. The model was separately tested for all 3 forms, and 
due to the non-normality present, the model was also evalu-
ated using bootstrapping with 2,000 replicates.22 The results 
of both analyses yielded comparable conclusions and results 
reported here were obtained from the bootstrap analyses. 
The model fit to the data was evaluated using 4 fit indices: 
chi-squared/df ratio (,3 good), the comparative fit index 
(.0.90 acceptable, .0.95 excellent), Tucker–Lewis Index 
(.0.90 acceptable, .0.95 excellent), and root mean square 
error of approximation (,0.08 acceptable, ,0.06 excellent).
Receiver operating characteristic curves were gener-
ated and the area under the curve (AUC) was compared to 
evaluate the validity of the 3 forms separately. Sensitivity 
and specificity values were calculated, with selected optimal 
cutoff values for screening purposes. Optimal cutoff values 
were selected based on 3 criteria: sensitivity and specificity 
should be above 0.8, sensitivity should be $ specificity, and 
Youden index ([sensitivity + specificity] - 1) should be as 
high as possible,23,24 but preferably $0.70.
Results
internal consistency and construct 
validity
Cronbach’s α was 0.91, 0.88, and 0.86 for the ESSENCE-Q 
parent-completed, telephone interview, and direct interview 
forms, respectively, with moderate-to-high item–total 
correlations (range 0.35–0.82).
The statistics assessing the adequacy of the model revealed 
good model fit for the ESSENCE-Q parent-completed and 
Table 1 Diagnoses of 200 children in the esseNce group
ESSENCE diagnosis N (%)
Attention deficit/hyperactivity disorder 12 (6.0)
Attention deficit/hyperactivity disorder and tics 1 (0.5)
autism spectrum disorder 37 (18.5)
autism spectrum disorder and intellectual developmental  
disorder
30 (15.0)
Attention deficit/hyperactivity disorder and intellectual  
developmental disorder
2 (1.0)
Behavioral syndrome 10 (5.0)
Borderline intellectual functioning 4 (2.0)
epilepsy 11 (5.5)
Epilepsy and speech and/or language disorder 3 (1.5)
Global developmental delay 21 (10.5)
intellectual developmental disorder 31 (15.5)
Intellectual developmental disorder and motor abnormality 9 (4.5)
intellectual developmental disorder and epilepsy 3 (1.5)
Motor disorder 10 (5.0)
Oppositional defiant disorder 4 (2.0)
Speech and/or language disorder 9 (4.5)
Speech and/or language disorder and attention deficit/ 
hyperactivity disorder
3 (1.5)
Abbreviation: esseNce, early symptomatic syndromes eliciting Neuro-
developmental clinical examinations.
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telephone interview forms, but poor model fit for the direct 
interview form (Table 3).
Sensitivity and specificity
The AUC of ESSENCE-Q parent-completed, telephone inter-
view, and direct interview forms was (95% CI [CI]): 0.96 (0.93–
0.99), 0.91 (0.86–0.95), and 0.91 (0.86–0.97), respectively.
Table 4 shows the most relevant cutoff values, sensi-
tivities, specificities, and Youden indices for the ESSENCE 
scores of 2–6 points. Considering the predefined criteria, an 
optimal cutoff for the ESSENCE-Q parent-completed form 
of $3 had sensitivity of 0.96 (95% confidence interval [CI]: 
[0.86–0.99]), specificity of 0.84 (95% CI: [0.75–0.91]), and 
Youden index 0.80 (95% CI: [0.61–0.90]). The ESSENCE-Q 
telephone interview form had an optimal cutoff $4 based on 
the predefined criteria, but its diagnostic accuracy was greater 
with a cutoff $5 (Youden index 0.71), even its sensitivity 
(0.82, 95% CI: [0.72–0.89]) was slightly below the speci-
ficity (0.89, 95% CI: [0.81–0.94]). The ESSENCE-Q direct 
interview form with an optimal cutoff of $5 had sensitivity 
of 0.86 (95% CI: [0.77–0.96]), specificity of 0.88 (95% 
CI: [0.74–0.95]), and Youden index of 0.74 (95% CI: 
[0.52–0.85]).
gender and age differences
The diagnostic accuracy for all 3 ESSENCE-Q forms was 
similar when screening boys and girls separately. All forms had 
slightly greater diagnostic accuracy for children aged 1–3 years 
than for those aged 3–6 years (Table 5). The significance of 
the differences was not tested due to small numbers.
Discussion
The ESSENCE-Q is a brief screener for identification of 
children who may have neurodevelopmental difficulties. It 
was developed in this study for 7 South Slavic languages, 
namely, Bosnian, Bulgarian, Croatian, Macedonian, Mon-
tenegrin, Serbian, and Slovenian. This is the first time that 
1 measure was simultaneously developed and validated for 
this language group and only the third psychometric study 
testing the ESSENCE-Q.
The internal consistency of the ESSENCE-Q was 
found to be good for all 3 forms, ie, direct or telephone 
interview or parent-completed, with moderate-to-high item–
total correlations. In a study with the Japanese version, a 
parent-completed form, internal consistency was also good, 
although lower than in our study.12 These data for internal 
consistency indicate that 12 ESSENCE-Q items have high 
homogeneity in measuring aspects of child development. In 
addition, we tested the construct validity of the ESSENCE-Q 
forms for the first time. The fit indices indicated accept-
able fit of the data to the model for the parent-completed 
and telephone interview forms, but poor model fit for the 
direct interview form. In this regard, the latent underly-
ing structure of neurodevelopment in the ESSENCE-Q 
is associated with 12, conceptually relevant items in the 
parent-completed and telephone interview forms, while in 
the direct interview form, the underlying structure may not 
be observed by all items. This result may indicate that the 
direct interview form could be conceptually different than 
the other 2 forms, with ,12 items sufficient to represent 
neurodevelopment. In addition, there could be a genuine 
problem with the construct manifested through the direct 
interviewing, which includes some degree of combination 
of interview and observation, so that the actual recording of 
concern or not is, in fact, a partly investigator-based clinical 
judgment. Nevertheless, the observed difference could arise 
Table 2 Age and gender distributions of the ESSENCE and non-ESSENCE groups
Age and gender 
distribution
Parent-completed form,  
n=147
Telephone interview form, 
n=188
Direct interview form,  
n=116
ESSENCE
n=48
Non-ESSENCE
n=99
ESSENCE
n=88
Non-ESSENCE
n=100
ESSENCE
n=52
Non-ESSENCE
n=64
Mean age in years (sD) 3.73 (1.18)* 2.67 (1.04) 4.04 (1.25)* 3.24 (1.34) 3.36 (1.18) 3.63 (1.33)
Male gender, n (%) 36 (75)** 52 (52.5) 60 (68.2)** 51 (51) 46 (71.9)** 25 (48.1)
Notes: *P,0.05 for t-test pairwise comparisons in age between the ESSENCE and non-ESSENCE group; **P,0.02 for chi-squared test in comparisons for gender between 
the esseNce and non-esseNce groups.
Abbreviation: esseNce, early symptomatic syndromes eliciting Neurodevelopmental clinical examinations.
Table 3 Goodness of fit indexes for the ESSENCE-Q forms
ESSENCE-Q form Chi-squared/df CFI TLI RMSEA
Parent-completed* 1.95 0.95 0.93 0.08
Telephone interview** 2.19 0.92 0.90 0.08
Direct interview*** 3.01 0.82 0.76 0.13
Notes: Root mean square error of approximation. *Error correlations between 
items “general development” and “motor development/milestones”, items “activity 
(overactivity/passivity) or impulsivity” and “attention/concentration/listening”, and 
items “sensory reactions” and “mood”; **Error correlations between items “social 
interaction/interest in other children” and “behavior”; ***Error correlations between 
items “general development” and “motor development/milestones” and items “activity 
(overactivity/passivity) or impulsivity” and “attention/concentration/listening”.
Abbreviations: CFI, comparative fit index; ESSENCE-Q, Early Symptomatic 
Syndromes Eliciting Neurodevelopmental Clinical Examinations – Questionnaire; 
RMSEA, root mean square error of approximation; TLI, Tucker–Lewis index.
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due to the sample size, which was smaller in the group of 
parents directly interviewed than for the other 2 groups.25 
Thus, additional factor analysis and item-response theory 
studies are needed to draw valid conclusions about the 
ESSENCE-Q and whether all forms have the same underly-
ing construct of neurodevelopment. Further testing indicated 
that the accuracy of the ESSENCE-Q in differentiating chil-
dren with NDDs and children with typical developmental 
trajectories was excellent for all 3 forms, but best for the 
parent-completed form (unlike in the Japanese study in 
public health, where the public health nurse had the “best” 
result).15 Analyzing the values for its sensitivity, specificity, 
and Youden index, the best cutoff values were found to 
be $3 points for the ESSENCE-Q parent-completed form 
and $5 points for the ESSENCE-Q telephone and direct 
interview forms. Nevertheless, the score of 2 points for the 
parent-completed form or 3 points for the interview form 
could also serve as good cutoffs, considering that its sen-
sitivity and specificity values were above 0.87 and 0.65, 
respectively, which might be sufficient for screening NDDs. 
Hatakenaka et al12 in Japan showed that optimal cutoff 
values could be 3–5 points for the parent-completed form 
used in a clinical setting. The same group demonstrated that 
for public screening, an optimal cutoff value could be that of 
3 points for the parent-completed form or even 2 points for 
the interviews.15 We would recommend that a clinician or 
researcher uses higher cutoffs when screening in a clinical 
setting, because the percentage of false positives and false 
negatives would be lowest.
Finally, the results indicated that all 3 ESSENCE-Q 
forms could differentiate children with NDDs and children 
with typical developmental trajectories when gender was 
taken into account and its diagnostic accuracy was similar 
for boys and girls. In this regard, gender may not affect the 
validity of ESSENCE-Q screening, which is particularly 
relevant considering that some NDDs are more prevalent 
among boys than girls.1 On the other hand, there was a 
difference when screening younger vs older children, and 
all 3 forms had slightly greater diagnostic accuracy for 
children aged 1–3 years than for those aged 3–6 years. 
Table 4 Cutoff, sensitivity, specificity, and Youden index values for the ESSENCE-Q parent-completed, telephone interview, and direct 
interview forms
Cutoff 
value
Parent-completed form Telephone interview form Direct interview form
Sensitivity 
(95% CI)
Specificity 
(95% CI)
Youden index 
(95% CI)
Sensitivity 
(95% CI)
Specificity 
(95% CI)
Youden index 
(95% CI)
Sensitivity 
(95% CI)
Specificity 
(95% CI)
Youden index 
(95% CI)
$2 0.98
(0.89–0.99)
0.78
(0.68–0.86)
0.76
(0.57–0.85)
0.93
(0.86–0.98)
0.67
(0.57–0.76)
0.60
(0.43–0.74)
0.94
(0.85–0.98)
0.46
(0.32–0.61)
0.40
(0.17–0.59)
$3 0.96
(0.86–0.99)
0.84
(0.75–0.91)
0.80
(0.61–0.90)
0.87
(0.80–0.94)
0.73
(63.2–81.4)
0.62
(0.43–0.75)
0.92
(0.83–0.98)
0.65
(0.51–0.78)
0.57
(0.27–0.76)
$4 0.88
(0.75–0.95)
0.92
(0.85–0.96)
0.80
(0.59–0.90)
0.84
(0.75–0.91)
0.82
(0.73–0.89)
0.66
(0.48–0.80)
0.89
(0.79–0.95)
0.81
(0.67–0.90)
0.70
(0.46–0.85)
$5 0.83
(0.69–0.93)
0.94
(0.87–0.98)
0.77
(0.57–0.90)
0.82
(0.72–0.89)
0.89
(0.81–0.94)
0.71
(0.53–0.84)
0.86
(0.75–0.93)
0.88
(0.77–0.96)
0.74
(0.52–0.85)
$6 0.77
(0.63–0.89)
0.95
(0.87–0.98)
0.72
(0.50–0.87)
0.78
(0.68–0.87)
0.90
(0.82–0.95)
0.68
(0.50–0.82)
0.78
(0.66–0.88)
0.90
(0.79–0.97)
0.68
(0.45–0.85)
Abbreviations: CI, confidence interval; ESSENCE-Q, Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations – Questionnaire.
Table 5 Sensitivity, specificity, and Youden index values for the ESSENCE-Q parent-completed, telephone interview, and direct 
interview forms considering gender and age groups
Group Parent-completed form Telephone interview form Direct interview form
Sensitivity 
(95% CI)
Specificity 
(95% CI)
Youden index 
(95% CI)
Sensitivity 
(95% CI)
Specificity 
(95% CI)
Youden index 
(95% CI)
Sensitivity 
(95% CI)
Specificity 
(95% CI)
Youden index 
(95% CI)
Boys 0.97
(0.86–0.99)
0.81
(0.68–0.90)
0.78
(0.54–0.89)
0.82
(0.69–0.91)
0.90
(0.79–0.97)
0.72
(0.48–0.88)
0.85
(0.71–0.94)
0.88
(0.68–0.95)
0.73
(0.53–0.85)
girls 0.92
(0.62–0.99)
0.87
(0.74–0.95)
0.79
(0.36–0.94)
0.82
(0.63–0.94)
0.88
(0.75–0.95)
0.70
(0.38–0.89)
0.89
(0.66–0.99)
0.89
(0.74–0.98)
0.78
(0.52–0.89)
age 
1–3 years
0.94
(0.71–0.99)
0.92
(0.83–0.97)
0.86
(0.54–0.96)
0.87
(0.66–0.97)
0.96
(0.87–0.99)
0.83
(0.53–0.96)
0.86
(0.65–0.97)
100
(0.81–100)
0.86
(0.64–0.96)
age 
3–6 years
0.97
(0.83–0.99)
0.60
(0.39–0.79)
0.57
(0.22–0.78)
0.80
(0.68–0.89)
0.82
(0.68–0.91)
0.62
(0.36–0.80)
0.90
(0.77–0.97)
0.83
(0.66–0.93)
0.73
(0.57–0.86)
Abbreviations: CI, confidence interval; ESSENCE-Q, Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations – Questionnaire.
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esseNce-Q: slavic language versions for developmental screening
Hatakenaka et al15 showed that there could be some cross-
cultural differences and that, in Japan, the ESSENCE-Q 
might have better validity for screening boys and older 
children and cutoff values could be different when screening 
the same children at age 18 and 36 months of age. Accumu-
lated evidence also indicates that the outcome of screening 
in NDDs could vary depending on children’s age and that 
diagnostic accuracy could be greater with more advanced 
age.11,26 Thus, it would be relevant to take age into account 
when screening with the ESSENCE-Q.
Several limitations need to be considered. First, 
included children were not assessed through a unique diag-
nostic system or with a common diagnostic/psychologi-
cal assessment throughout the included centers, whereas 
there was no such a common method to implement. This 
is particularly relevant for children with NDDs, whereas, 
it is possible to judge the presence and levels of the same 
NDDs based only on specific measurement methods. 
Second, convenience sampling in each country was con-
sidered and this is an important limitation also, because 
the assessment with the ESSENCE-Q could be affected 
by the diagnosis of or previous contacts with the research 
team of the child and the family included. In addition, an 
unequal age and gender distribution was present, which 
prevented us from creating distinct age × gender categories 
to test the measurement properties across these groups. 
Next, we did not simultaneously evaluate different forms 
for each child, for example a parent-completed and direct 
interview, in order to compare directly the measurement 
properties of the forms as it was done in the previous 
study.12 Finally, the results could be biased due to the 
usage of the questionnaire’s data from similar languages, 
yet with different dialects.
Conclusion
This study provided additional data supporting good psy-
chometric properties of the ESSENCE-Q as a screening 
questionnaire for NDDs. The ESSENCE-Q in the South 
Slavic languages developed here, namely, Bosnian, Bul-
garian, Croatian, Macedonian, Montenegrin, Serbian, and 
Slovenian, is a promising brief screener for identification 
of children who may have neurodevelopmental difficulties 
in clinical settings, either as a parent-completed, telephone 
interview, or direct interview form. Recruiting more chil-
dren and addressing the aforementioned limitations, we will 
continue with the project and further test the ESSENCE-Q 
in additional settings, such as primary care or public health 
screening.
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